Navigation Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Navigation Wealth Management's MRNA Position: Q4 2022 in Review
Navigation Wealth Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 154 shares — an estimated $18K sold.
Navigation Wealth Management first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $52K in Q3 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.
- Navigation Wealth Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
- Navigation Wealth Management sold 154 Moderna shares in Q4 2022, an estimated $18K.
- Navigation Wealth Management first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
- Navigation Wealth Management's Moderna position peaked at $52K in Q3 2021.
- 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.
Based on Navigation Wealth Management's 13F filing for Q4 2022, filed 6 Jan 2023.